This is consistent with the finding that JAK2 V617F, albeit at low allelic burden, has been detected commonly in aged, healthy individuals, along with clonal hematopoiesis, and has been considered as one of the pre-leukemia-associated mutations [99,100,101,102,103]. The gene discussed is JAK2; the disease is leukemia.